182 related articles for article (PubMed ID: 7533218)
1. Expression of C-terminal src kinase in human colorectal cancer cell lines.
Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
[TBL] [Abstract][Full Text] [Related]
2. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.
Han NM; Curley SA; Gallick GE
Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
Marchetti D; Parikh N; Sudol M; Gallick GE
Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
[TBL] [Abstract][Full Text] [Related]
5. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification, and initial characterization of human Yes protein tyrosine kinase from a bacterial expression system.
Sun G; Budde RJ
Arch Biochem Biophys; 1997 Sep; 345(1):135-42. PubMed ID: 9281320
[TBL] [Abstract][Full Text] [Related]
7. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
[TBL] [Abstract][Full Text] [Related]
8. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
9. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
10. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma.
Cam WR; Masaki T; Shiratori Y; Kato N; Ikenoue T; Okamoto M; Igarashi K; Sano T; Omata M
Cancer; 2001 Jul; 92(1):61-70. PubMed ID: 11443610
[TBL] [Abstract][Full Text] [Related]
11. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.
Moasser MM; Srethapakdi M; Sachar KS; Kraker AJ; Rosen N
Cancer Res; 1999 Dec; 59(24):6145-52. PubMed ID: 10626805
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of p62c-yes in normal, hyperplastic and neoplastic human epidermis.
Krueger J; Zhao YH; Murphy D; Sudol M
Oncogene; 1991 Jun; 6(6):933-40. PubMed ID: 2067846
[TBL] [Abstract][Full Text] [Related]
14. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation.
Sun G; Sharma AK; Budde RJ
Oncogene; 1998 Sep; 17(12):1587-95. PubMed ID: 9794236
[TBL] [Abstract][Full Text] [Related]
15. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
Brickell PM
Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
[TBL] [Abstract][Full Text] [Related]
16. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.
Ottenhoff-Kalff AE; Rijksen G; van Beurden EA; Hennipman A; Michels AA; Staal GE
Cancer Res; 1992 Sep; 52(17):4773-8. PubMed ID: 1380891
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.
Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK
Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911
[TBL] [Abstract][Full Text] [Related]
19. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
20. Src family kinases and HER2 interactions in human breast cancer cell growth and survival.
Belsches-Jablonski AP; Biscardi JS; Peavy DR; Tice DA; Romney DA; Parsons SJ
Oncogene; 2001 Mar; 20(12):1465-75. PubMed ID: 11313890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]